Kent Snyder

Director/Board Member at SENOMYX INC.

70 year

Health Technology

Consumer Services

Consumer Non-Durables

Profile

Kent Snyder is currently a Director at Senomyx, Inc. and a Director at VentiRx Pharmaceuticals, Inc. He was previously an Independent Director at Santarus, Inc. from 2011 to 2014.
He also served as a Director at BioAtla, Inc. and as the President-Global Commercial Operations at Agouron Pharmaceuticals LLC from 1991 to 2001.
Mr. Snyder holds an MBA from Rockhurst University and an undergraduate degree from the University of Kansas.

Kent Snyder active positions

Companies	Position	Start
SENOMYX INC.	Director/Board Member	-
VentiRx Pharmaceuticals, Inc. VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA.	Director/Board Member	-

All active positions of Kent Snyder

Former positions of Kent Snyder

Companies	Position	End
Santarus, Inc. Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ.	Director/Board Member	2014-01-01
Agouron Pharmaceuticals LLC Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA.	Corporate Officer/Principal	2001-09-30
BIOATLA, INC.	Director/Board Member	-

See the detail of Kent Snyder's experience

Training of Kent Snyder

Rockhurst University	Masters Business Admin
University of Kansas	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kent Snyder's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BIOATLA, INC.	Health Technology

Private companies	4
Agouron Pharmaceuticals LLC Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA.	Health Technology
Senomyx, Inc. Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA.	Consumer Non-Durables
Santarus, Inc. Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ.	Health Technology
VentiRx Pharmaceuticals, Inc. VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA.	Health Technology

See company connections